Insights into Mefenamic Acid-Induced Allergic Reactions: A Comprehensive Clinical and Research Review
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2024, Vol 8, Issue 1
Abstract
This study investigates the incidence of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with the over-the-counter non-steroidal anti-inflammatory drug (NSAID) mefenamic acid. Approximately 10% of individuals exposed to mefenamic acid experience DRESS syndrome, a severe and potentially fatal allergic reaction characterized by fever, skin rash, lymphadenopathy, hematological abnormalities, and internal organ involvement. Leukocytosis with eosinophilia (90%) and mononucleosis (40%) has been linked to certain cases, emphasizing the diversity of clinical presentations. The causative medication must be promptly discontinued upon identification of DRESS syndrome, with documented evidence indicating improved prognosis with early drug removal. Despite the severity of these reactions, the study sheds light on the alarming accessibility of mefenamic acid and other banned medications in developing nations, particularly exemplified by the Indian Pharmacopoeia Commission’s alert on mefenamic acid issued on December 7, 2023. The lack of effective law enforcement and medical awareness poses significant challenges, allowing banned drugs, including Nimesulide and Rofecoxib, to persist in the market despite being banned by the USFDA. This research underscores the critical need for global collaboration to address regulatory gaps, enhance medical awareness, and enforce stringent measures to restrict the availability of harmful medications in developing nations. Urgent attention to these issues is imperative to safeguard public health and ensure the effective implementation of drug regulations on a global scale.
Authors and Affiliations
Rutuja D*, Dimpal D, Ganesh S, Piyush B, Rushikesh B, Kajal P and Dhananjay P
Keywords
Related Articles
- EP ID EP751866
- DOI 10.23880/oajpr-16000295
- Views 9
- Downloads 0
Computer-Based Pharmacognosy: A Review
In search of modern ways to increase secondary metabolites production in plants, implement genetic engineering, and produce green pollution-free medicinal plants, modern computer-based techniques must be regarded. The in...
Tamoxifen: Pharmacokinetics and Pharmacodynamics
Tamoxifen is the hormone therapy of choice in pre-menopausal estrogen receptor positive breast cancer in women and sometimes in post-menopausal women. The environmental and genetic factors widely affect the pharmacokinet...
Lercanidipine Over Other Calcium Channel Blocker in Elderly Patients & its Renal Protection in Future
A calcium channel blocker called lercanidipine shows promise as a treatment for hypertension, especially in older people. Exhibiting greater effectiveness in comparison to other calcium channel blockers, it presents enc...
A Review on Formulation and In-Vitro Evaluation of Sustained Release Tablet of Isoniazide by Using Natural and Synthetic Polymer
The goal of this study was to combine many polymers to create an isoniazide tablet with a sustained release. In this piece of work, guar gum, xanthum gum, and eudragit L100 are the polymers employed. The FTIR and UV ana...
Benomyl- or Carbendazim-Induced Androgen Receptor Disrupting Might Lead to Spinal and Bulbar Muscular Atrophy in Multi-Generations of Rats
We have reported that benomyl and its metabolite carbendazim induced reproductive and developmental toxicity and endocrine-disrupting activity in rats. The exactly underlying mechanism of reproductive and developmental t...